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Objective: To identify psychometrically evaluated patient-
reported outcome measures reflective of ‘real-life’ function 
(active and passive) for application following focal rehabili-
tation interventions in the lower limb after stroke or brain 
injury.
Data sources: A literature search conducted in MEDLINE, 
CINAHL, Embase, Web of Science, PubMed, National 
Health Service National Research Register, MRC Clinical 
Trials directory, Database of Abstracts of Reviews of Effects 
(DARE), Google Scholar and the Cochrane Database of Sys-
tematic Reviews.
Study selection: Interventional study designs using patient-
reported outcome measures for outcome evaluation meeting 
the review objective.
Data extraction: Evaluation of the psychometric properties 
used the COnsensus-based Standards for the selection of 
health Measurement Instruments (COSMIN) process, by 
two independent reviewers reaching consensus, with adjudi-
cation by a third reviewer. 
Data synthesis: One-hundred and thirteen studies were iden-
tified following initial review of the abstracts, yielding 12 out-
come measures. Eight measures were identified, which were 
relevant to real life functional performance. These were the 
Brain Injury Community Rehabilitation Outcome, Climb-
ing Stairs Questionnaire, Human Activity Profile, Lower Ex-
tremity Functional Scale, Nottingham Extended ADL Index, 
Rivermead Mobility Index (RMI), Sickness Impact Profile, 
Stroke Impact Scale. 
Conclusions: All measures addressed active function, with 
none evaluating passive function. The RMI met most psy-
chometric criteria, but may have a ceiling effect for high 
functioning patients.
Key words: systematic review; outcome assessment; psycho-
metrics; lower limb; function; stroke; brain injuries.
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INTRODUCTION
The rehabilitation process for patients who have suffered a 
neurological event such as stroke or brain injury should be fo-
cused on the needs of the individual and be person-centred (1, 
2). The views of patients within this process of rehabilitation 
are particularly important (3, 4). Patient-Reported Outcome 
Measures (PROMs) are standardised, validated questionnaires 
that are completed by patients to measure their perceptions of 
their own functional status and wellbeing (5). PROMs have been 
identified as a method of involving patients in evaluating their 
ability and outcome following intervention (5, 6). PROMs also 
have the benefit of evaluating what patients do in their daily lives 
rather than only in the clinic setting and are therefore particularly 
relevant to the evaluation of person-centred outcomes (5, 7).
Brain injury or stroke often significantly impact motor 
function in the leg (8–11). Whilst many patients will recover 
to some degree of useful function in their lower limb, for a 
minority the limb effectively becomes a passive object to be 
cared for, either by the individual themselves or by a carer and 
may interfere with function (12–14). 
Interventions for the lower limb may therefore be focused on 
a wide range of goals. At the higher level, interventions such as 
functional electrical stimulation (FES) or gait re-training may 
target recovery of mobility, walking and in some cases running. 
At a lower level, interventions such as spasticity management 
may be directed more towards goals in ‘passive’ function, such 
as making it easier to maintain perineal hygiene (14). 
Outcome measurement is required to determine the effective-
ness of rehabilitation interventions (15–17). Whether applied 
in clinical practice or for research, measures need to be valid, 
reliable and responsive to clinically relevant change (18, 19). 
Global measures of function in daily activities, such as the 
Barthel Index (14, 16), provide a general assessment of inde-
pendence but are often unresponsive to focal interventions. 
Small changes which may be extremely important to the patient 
and/or their carers are easily lost amongst the larger number 
of unchanging items (20–22). 
For these reasons, a number of motor function tests of gait, 
walking and balance have been developed, for example the 
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Berg balance test, 10-m walk test and the timed-up-and-go 
(TUG) test (23, 24). Conducted under close observation in 
the clinic, these may provide a more responsive and objec-
tive measure of motor activity (23, 24). However, they do not 
necessarily reflect how the person actually functions in terms 
of mobility in their normal environment, and it is generally not 
practical to obtain this information through 24-h observation in 
the home setting (2, 7). Instead, this information on ‘real life’ 
function may be gathered through direct enquiry (self-report) 
from the patient and/or carer, for example using a task inven-
tory administered by structured interview, self-completion 
questionnaire or PROM (25).
The aim of this systematic review was to identify valid and 
reliable patient (and/or carer) reported outcome measures that 
have been applied to assess changes following focal rehabilita-
tion interventions in the lower limb in the context of stroke or 
brain injury, and are reflective of ‘real-life’ function (activity 
according to the International Classification of functioning, 
Disability and Health - ICF) for both active and passive func-
tion tasks (26).
METHOD
The systematic review was performed by the authors in 3 stages, as 
described below, according to the methodology described by Ashford 
et al. (2). The review methodology is published and registered on the 
PROSPERO registry (CRD42013005046), Centre for Reviews and 
Dissemination, University of York. The Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement provides 
guidance on the most appropriate methods of presenting systematic review 
data and these principles were used, in the presentation of results (27).
Measure selection criteria were: 1) Application of the PROM in 
acquired brain injury (including stroke and traumatic brain injury). 
The stage 1 systematic search is used to identify measures applied 
in this area of practice. Studies are therefore not excluded on the 
basis of methodological design. 2) Measures are retained at stage 3 
provided they address psychometric properties included in the COS-
MIN  criteria (18). Psychometric evaluation is undertaken on all the 
retained measures.
The exclusion criteria were: 1) Studies not evaluating any aspect 
of lower limb function. 2) Outcome measurement tools which are 
not PROMs. 3) Psychometric evaluation cannot be identified on the 
measures from the literature.
Stage 1. Data sources
In stage 1, a pool of possible measures was identified from a broad-
based search of intervention studies. The following data sources were 
searched including Ovid MEDLINE, Ovid MEDLINE In-process, 
CINAHL, Embase, Web of Science, PubMed, National Health Service 
National Research Register, MRC Clinical Trials directory, Database 
of Abstracts of Reviews of Effects (DARE), Google scholar and the 
Cochrane Database of Systematic Reviews. The keywords used were 
leg, lower limb, hip, knee, ankle, foot, stroke, post stroke, cerebro-
vascular accident, CVA, cerebral haemorrhage, brain haemorrhage, 
haemorrhage, haematoma, hematoma, brain injuries, outcome meas-
urement, outcome assessment, function (ing/al), activity, walking, 
transfers and mobility.
Stage 2. Study selection
The title was reviewed to identify potentially relevant studies. The 
abstract was then reviewed if the title was found to be relevant. When 
the abstract indicated relevance, the full text paper was retrieved and a 
final decision made about inclusion of the study. Initial selection was 
undertaken by the author and was then evaluated by a second reviewer; 
any areas of disagreement were discussed. Publications selected were 
restricted to those in the English language.
Measures were then excluded if they did not use a method of 
assessment reflective of ‘real-life’ function to measure day-to-day 
performance. In Stage 2, selected measures were considered to have 
‘real-life’ relevance if they assessed day-to-day performance in the per-
son’s normal environment, as opposed to performance when observed 
under test conditions (such as a standardised test in a clinic setting).
Stage 3. Data extraction and synthesis
In stage 3 a second systematic search was conducted, to enable evalu-
ation of the published evidence for the psychometric properties of 
the selected measures, in addition to searching the reference lists of 
publications selected at stage 2. The COnsensus-based Standards for 
the selection of health status Measurement Instruments (COSMIN) 
checklist was applied in the study evaluation for assessing the metho-
dological quality of the measurement instruments at stage 3 (18). 
The names of measures identified in stage 2 were used as terms 
for a further search of the electronic databases to obtain original and 
any subsequent publications concerning their development and psy-
chometric evaluation. MEDLINE, CINAHL and the reference lists of 
identified publications containing relevant outcome measures were 
then searched to identify further literature on the development of these 
outcome measures and their psychometric properties. Additional search 
terms used were: psychometric evaluation, testing, validity, reliability, 
application and clinical application. Authors of outcome measures were 
contacted for further details when required, in addition to searching 
the reference lists of the psychometric publications identified. 
Based on this published literature, the psychometric properties of 
each measure were evaluated against the following review criteria 
based on the COSMIN process: Practicality for use in everyday prac-
tice: time to complete, burden, readability. Validity and reliability: 
content validity, internal consistency, construct validity, floor and 
ceiling effect, test-retest reliability, agreement. Responsiveness to 
change: demonstration of change following focal lower limb interven-
tion, interpretability and minimal important change (MIC).
Descriptive information was tabulated for each of the selected meas-
ures including; the items in the measure, the methods of administration 
and the method of scoring applied. Two reviewers independently evalu-
ated each measure using these criteria. Findings were then compared 
and any discrepancies resolved through discussion. The option was 
available for a third reviewer to resolve any areas of disagreement 
following comparison, but was not used.
Procedure used to evaluate each measure 
The quality criteria developed by Bot et al. (19) were then used to 
operationalize the evaluation of the quality of each instruments proper-
ties, summarising each variable as adequate (+), doubtful (±), or poor 
quality (–), or as unknown (?) if insufficient information was available.
Administrative burden
Administrative burden was assessed using the same scoring method, 
modified as follows: Easy (+), when dichotomous items were simply 
summed; Moderate (±), when an ordinal or visual analogue scale was 
used to quantify individual items then summed, and Difficult (–) when 
a summary score was applied in combination with a formula. Timing 
Box. Active and passive function
Active function: Where a functional task is performed by active 
movement of the individual’s affected limb e.g. to stand, walk or 
actively participating in lower limb dressing.
Passive function: Where a task is carried out on the affected limb 
by the individual using the unaffected upper limb or by a carer e.g. 
cleaning the perineal area or putting on trousers or positioning the 
limb.
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for completion of the measure was also rated as positive for measures 
completed within 10 min. Outcome measures should be both practi-
cal to use in routine practice and retain psychometric properties, thus 
ensuring the utility of the data produced (28, 29). 
Validity
The instruments were evaluated for content and construct validity on 
the scale used for all psychometric properties. Content validity, evalu-
ates that the instrument covers all the relevant concepts or domains 
(30). A positive rating for content validity was given when there 
was evidence that either patients, carers or other experts had been 
consulted regarding the initial selection of items (e.g. through focus 
groups or surveys) or had provided evaluation or feedback as part of 
the development. Construct validity originates from the idea that the 
new measure evaluates the construct it has been designed to measure 
(31). A positive rating for construct validity was given if there was 
evidence that the measure was based on hypothetical constructs, which 
had been tested and supported during its evaluation.
Internal consistency
Internal consistency refers to the interrelatedness of a set of items (32), 
and is often attributed to homogeneity of the items. A positive rating 
for internal consistency was given if the factor structure of the measure 
had been tested through factor analysis, or where ratings for Cronbach’s 
alpha were between 0.70 and 0.95 for each dimension or subscale.
Floor and ceiling effects
Floor and ceiling effects were considered present if more than 15% of 
respondents achieved the highest or lowest possible score, respectively. 
Reproducibility (reliability)
Reliability is concerned with detecting the amount of error occurring 
during application of a measurement instrument (30). Test–retest reli-
ability was rated as positive if repeat testing of the same condition had 
yielded comparable results, e.g. an intraclass correlation coefficient 
(ICC) of greater than 0.70 for total scores. In item-by-item analyses, 
agreement was also rated as positive if it had been evaluated and shown 
to be satisfactory, using accepted statistical methods such as the Kappa 
coefficient or standard error of measurement.
Responsiveness
Responsiveness is defined as ‘the ability of an instrument to measure a 
meaningful or clinically important change’ (33), when change occurs 
and record ‘no-change’ when the condition is stable. Responsiveness 
was rated as positive if the measure had demonstrated significant 
change in response to intervention, in the context of an appropriate 
study design.
Interpretability
Interpretability is the degree to which qualitative meaning can be as-
signed to quantitative scores (34). Positive ratings were given if at least 
two types of information were given to aid in understanding of the scores. 
Information considered included, means and standard deviations of the 
score totals before and after treatment, information in relation to other 
clinical variables, which might be expected to change, or information 
on the minimum change in score that might be clinically meaningful 
using the MIC (or MCID, Minimal Clinically Important Difference).
RESULTS
Stage 1. Data sources
A summary of the stages of review, according to the PRISMA 
measure selection flow diagram, is given in Fig. 1. The search 
yielded 19,942 studies, including primary reports, abstracts and 
conference proceedings. One hundred and thirteen studies were 
identified following initial review of the abstracts as including 
measures of functional outcome following focal lower limb 
intervention, yielding a total of 12 outcome measures after 
stage 1 (see Fig. 1). 
Stage 2. Study selection
Eight measures were identified, which met both stage 1 and stage 
2 criteria (i.e. were relevant to real life functional performance). 
These were the Brain Injury Community Rehabilitation Outcome 
(BICRO) (35); Climbing Stairs Questionnaire (36, 37), Human 
Activity Profile (38–50), Lower Extremity Functional Scale 
(51–55), Nottingham Extended ADL Index (56–64), Rivermead 
Mobility Index (8, 65–78), Sickness Impact Profile (9, 79–93), 
Stroke Impact Scale (Table I) (3, 4, 10, 11, 94–104). The scaling 
methods, number of items and methods of administration for 
these measures are also shown in Table I.
Stage 3. Extraction and synthesis
The detailed evaluation of the properties of the selected meas-
ures is presented in Table II. The COSMIN checklist for as-
sessing the methodological quality of studies on measurement 
properties of health status measurement instruments (18), was 
applied in study evaluation. 
Table III shows the categorisation of content of each of the 
8 identified measures. The item categories form a conceptual 
hierarchy of increasing difficulty. 
Fig. 1. PRISMA Measure selection flow diagram.
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
First systematic search undertaken 
(n=19,942) 
Titles and abstracts reviewed 
(n=726)  
Excluded: Not relevant to 
clinical group (n=19,216) 
Excluded: No functional 
outcome evaluation method 
used (n=613) 
Full text retrieved (n=113) 
Outcome measures identified n =12 
(from 22 publications) 
Second systematic search undertaken 
to identify psychometric evaluation 
studies 
Excluded: 
1. Not self-report (n=78) 
2. Not relevant to clinical 
group (n=6) 
3. Not standardised measure 
(n=7) 
Stage 2. Criteria 
Stage 1. Criteria 
Excluded: 
1. No psychometric 
evaluation (n=1) 
2. Not evaluating active or 
passive function (n=1) 
3. Not relevant to clinical 
group (n=1) 
4. No specific element for 
lower limb function (n=1) 
Stage 3. Criteria 
Outcome measures evaluated (n=8) 
BICRO, Climbing Stairs 
Questionnaire, Human Activity 
Profile, Lower Extremity Functional 
Scale, Nottingham Extended ADL 
Index, Rivermead Mobility Index, 
Sickness Impact Profile, Stroke 
Impact Scale 
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The administrative burden was adequate for 7 of the meas-
ures, but the HAP has a significant burden with time for com-
pletion (over 20 min in many studies) and contains 94 items. 
For the HAP construct validity was considered unclear accord-
ing to the review criteria, with a resulting ‘doubtful’ rating. 
DISCUSSION
In this systematic review of patient-reported measures of lower 
limb function, 8 measures were identified. All the measures had 
been applied in neurological populations, with 7 having under-
gone specific psychometric evaluation for this group (exclud-
ing the LEFS). Three of the measures specifically focused on 
evaluating lower limb function (CSQ, LEFS and RMI). The 5 
remaining measures incorporated lower limb function in among 
self-report on other functional items or sub-scale dimensions. All 
the measures were self-reported by patients and some could also 
be completed by interview (see Table I). All measures identified 
following the search application, address active function within 
the activity domain of the ICF, with none evaluating passive 
function. Clinically-based measures of active function, such 
as the 10-m walk test or 6-min walk (24), are useful and valid 
Table I. Selected measures of function
Outcome measure Method and procedure of scoring Context for development
Brain Injury Community 
Rehabilitation Outcome 
Scales (BICRO)
(35)
Items: 39 items; 8 domains (Personal care-6 items; Mobility-6 items; Self-organisation-6 
items; Contact with partner/children-2 items; Contact with parents/siblings-3 items; 
Socialising-6 items; Productive employment-4 items; Psychological well-being-6 items)
Scoring: 0–5 scale with variation in the descriptors according to the domain
Administration: Patient self-report
Modifications/versions: Original version in English only
Developed with patients with 
varied neurological conditions 
(TBI, Stroke, other ABI and 
MS)
Climbing Stairs 
Questionnaire (CSQ)
(36, 37)
Items: 15 items in one domain for ascending and descending stairs
Scoring: Dichotomous variables
Administration: Patient self-report or interview
Modifications/versions: Original version in English only
Developed with patients with 
mixed lower limb impairment 
including stroke
Human Activity Profile 
(HAP)
(38–50)
Items: 94 items in one domain of ‘activity’
Scoring: 0–3 scale
Administration: Patient or carer self-report or interview
Modifications/versions: Original version in English and Portuguese
Developed with patients of 
mixed aetiology including 
stroke
Lower Extremity 
Functional Scale (LEFS)
(51–55)
Items: 20 items in one domain of lower limb activity
Scoring: 0–5 scale of task difficulty
Administration: Patient or carer self-report or interview
Modifications/versions: Original version in English only
Developed in musculoskeletal 
problems, but applied in 
neurological conditions
Nottingham Extended 
ADL Index (N-ADL)
(56–64)
Items: 21 items in 4 domains (mobility, kitchen, domestic, and leisure) relevant to 
activities of daily living (ADL)
Scoring: 0–4 scale of undertaking task in past ‘few’ days
Administration: Patient or carer self-report or interview
Modifications/versions: Original version and extended version in English only
Developed with patients 
primarily with stroke (also 
multiple sclerosis)
Rivermead Mobility 
Index (RMI)
(8, 65–78)
Items: 15 items in one domain of lower limb activity
Scoring: yes/no (0–1 scale)
Administration: 14 self-report items and one clinician observation item (independent 
standing)
Modifications/versions: Original version in English, Italian, Dutch, German and 
Portuguese. A modified version of the measure is available, but is entirely scored by the 
clinician and is not self-reported by the patient
Developed with patients with 
acquired brain injury
Sickness Impact Profile 
(SIP)
(9, 79–93)
Items: 30 items in 8 domains (Body Care and Movement, Social Interaction, Mobility, 
Communication, Emotional Behaviour, Household Management, Alertness Behaviour, 
Ambulation)
Scoring: yes/no (0–1 scale)
Administration: Patient self-report or interview
Modifications/versions: Original 136 item version (SIP-136), which is burdensome to 
complete. A 68 item version (SIP-68) is also available. Original version and shortened 
versions in English and SIP-136 in German. An Italian version (SIP-23) for chronic pain 
is also available
Adapted from the SIP-68 to 
develop a new stroke specific 
version (SIP-30)
Stroke Impact Scale (SIS)
(3, 4, 10, 11, 94–104)
Items: 60 items in 9 domains (physical problems, memory and thinking, mood, 
communication, activities, mobility, hand use, participate in activities, recovery)
Scoring: 8 domains scored on a 5 point scale. 1 domain (recovery) scored with a single 
item on a numeric scale from 0 to 100
Administration: Patient self-report or interview
Modifications/versions: SIS 2.0, SIS 3.0 and SIS-16. Translated into a number of different 
languages, originally developed in English
Developed with patients 
primarily with stroke
TBI: traumatic brain injury; ABI: acquired brain injury; MS: multiple sclerosis.
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measures of performance in the clinical environment under test 
conditions (105). However, they evaluate performance under an 
artificial test situation and not functional performance carried out 
under normal circumstances (real-life) by the individual (105). 
PROM’s are therefore very relevant in understanding active and 
passive function ability in the day-to-day environment, though 
clinically based measures maybe a complementary approach.
Of the 3 measures which focused specifically on lower limb 
function (CSQ, LEFS and RMI), the CSQ only evaluated stair 
climbing. The LEFS and RMI evaluated mobility in a number 
of different common situations and were broadly hierarchical 
in nature starting with easier items and progressing to more 
difficult items. The RMI was shown to be a unidimensional 
scale with a hierarchy of easy-to-hard items (65). The diffi-
culty of items in the RMI was demonstrated to be stable when 
applied to different groups of patients assessed on different 
occasions in the same study. The RMI was developed and tested 
specifically with a population of patients with neurological 
impairment, while the LEFS was developed with patients with 
musculoskeletal problems, although it has been used in neu-
rological populations. The RMI is therefore recommended as 
a hierarchical measure of lower limb active function, but may 
not address function at a very high level and therefore have a 
ceiling effect. The LEFS could be an option to evaluate high 
level function from a patient report perspective, but would need 
specific testing for patients with neurological impairment and 
therefore can not be recommended without further evaluation, 
which would be valuable.
Search strategy and PROM selection
The search strategy applied has enabled selection of measure-
ment tools applied in research studies of patients with acquired 
brain injury including stroke. The use of two systematic 
searches has 1) facilitated the initial identification of relevant 
measures, and 2) been followed by a detailed evaluation of 
their published psychometric properties.
A range of patient-reported tools evaluating active function 
were identified, but no tool evaluating passive function. The 
search strategy focused on identifying patient reported tools, 
evaluating active and passive function. However, on reflection, 
the use of passive function as a search term, while appropriate, 
may have (in theory) excluded possible tools where authors 
Table II. Psychometric evaluation from the literature of the selected measures
Measure Time
Admin 
burden
Content
validity
Internal 
consistency
Construct 
validity
Floor/ceiling 
effect Reliability Agreement Responsiveness Interpretability MCID
BICRO + + + +b + + + + ? ? ?
CSQ + + + + + + + + ? ? ?
HAP ± ± + + ± + + + ±a ±a ?
LEFS +a +a +a ? +a + +a +a ±a ±a ±a
N-ADL + + + + + + + + + + +
RMI + + + + + ± + + ± ± ±
SIP + + + + + ± ? ? + – –
SIS + + + + + ± + + ± ± ±
Method or result was rated as: + Adequate; ± Doubtful; – Poor; ? No data available.
aNot adequately evaluated in a neurodisability or acquired brain injury patient group.
bDemonstrated on lower limb sub-scales.
Admin: Administrative; BICRO: Brain Injury Community Rehabilitation Outcome Scales; CSQ: Climbing Stairs Questionnaire; HAP: Human Activity 
Profile; LEFS: Lower Extremity Functional Scale; MCID: Minimal Clinically Important Difference; N-ADL: Nottingham Extended ADL Index; RMI: 
Rivermead Mobility Index; SIP: Sickness Impact Profile; SIS: Stroke Impact Scale.
Table III. Categorisation of items included in each measure
Item BICRO CSQ HAP LEFS N-ADL RMI SIP SIS
Turning in bed ü ü
Lying to sitting ü
Sitting ü
Transfer (bed to chair) ü ü ü
Transfer (bath or car) ü ü
Sit to stand ü
Standing ü ü ü
Walking indoors ü ü ü ü ü
Stairs ü ü ü ü
Walking outdoors ü ü ü ü ü
Running ü ü ü
Jumping/hopping ü
Endurance ü ü ü
BICRO: Brain Injury Community Rehabilitation Outcome Scales; CSQ: Climbing Stairs Questionnaire; HAP: Human Activity Profile; LEFS: Lower 
Extremity Functional Scale; N-ADL: Nottingham Extended ADL Index; RMI: Rivermead Mobility Index; SIP: Sickness Impact Profile; SIS: Stroke 
Impact Scale.
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had not used this term or concept. Other search terms such as 
‘personal care’ could have been considered. We are, however, 
not aware of such tools from our research or clinical experi-
ence. The search did not include all possible search engines 
(e.g. PEDro), but did include indexes of publications most 
relevant to measurement in this area of outcome evaluation. 
Other measures may have been relevant to evaluate of active 
function. For example the ABILOCO (106), though applied via 
interview and not directly patient-reported, would nevertheless 
be relevant to assessment of this dimension. However ABILO-
CO was not identified from the stage 1 search or subsequent 
evaluation. Alongside considering an increase in the breadth 
of search terms applied, inclusion of other search engines 
could also be considered in future expanding on this review. 
Evaluation of psychometric properties
The use of the COSMIN criteria in this systematic review 
has enabled a detailed and structured evaluation of the identi-
fied measures. The COSMIN criteria have built upon earlier 
work by Terwee and colleagues (107) and have incorporated 
both classical and item response methods into psychometric 
evaluation. In so doing, the COSMIN criteria make a useful 
contribution to the evaluation of patient-reported measures for 
clinically applied research and indeed practice. 
In the current systematic review a wide range of psychomet-
ric evaluation of the different measures could be identified. In 
some cases, psychometric evaluation has been limited to one or 
two studies (e.g. BICRO); however for many measures evalua-
tion was much more extensive. In some instances replication of 
psychometric evaluation had been possible largely confirming 
findings and supporting the properties being evaluated (e.g. 
RMI and N-ADL).
Passive vs. active function
While a number of measures addressing active function in the 
lower limb are available, no measure to evaluate passive func-
tion could be identified. This may be because active function 
improvement is more likely for greater numbers of patients in 
the lower limb, where smaller impairment improvement may 
lead to significant activity gain (e.g. small improvements in 
knee stability post stroke or brain injury may enable independ-
ent transfer and even walking). 
Nevertheless from a clinical perspective, a group of patients 
can be identified who will not regain function and mobility. 
In a proportion of these patients, difficulty with issues such 
as spasticity and contracture may cause challenges in caring 
for the leg as seen in the upper limb (2, 7, 108). However, 
differences with the presentation in the upper limb are likely 
in the lower limb, and ease of care related to issues such as 
perineal hygiene may be more common in brain injury rather 
than stroke. For example, focal botulinum toxin intervention 
for lower limb spasticity (for example to hip adductors for per-
ineal hygiene and catheter care), passive function improvement 
may be particularly important. In addition, passive function is 
possibly a more significant issue in the lower limb for people 
following spinal cord injury or those with severe multiple 
sclerosis. Passive function may be more significant in these 
groups, because of the bilateral nature of impairment in some 
cases and the severity of related symptoms such as spasticity. 
A review to consider if any additional PROMS are available in 
these patient populations would therefore be valuable. 
Summary and conclusions
The RMI is a practical and clinically applicable measure of 
mobility in neurologically impaired, and in particular acquired 
brain injury, patients. The RMI has robust psychometric 
measure ment properties, some of which have been replicated 
in a number of studies. Its dimensionality and measurement 
scaling properties have been evaluated and demonstrated using 
Rasch analysis and it can therefore be applied in a hierarchical 
manner to rate patient ability. It does however have a ceil-
ing effect and high function patients may require a different 
patient-reported tool. The LEFS could be considered in high 
function groups, but has not been tested in neurological popula-
tions and is therefore not recommended at present.
In this systematic review, no measure was identified that ad-
dressed passive function. While a number of patient-reported 
measures of active function are available, the lack of passive 
function measures remains a deficiency. There is therefore a 
need for a measure that can evaluate passive function changes 
following intervention and management in the lower limb. 
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